Literature DB >> 29553093

Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.

Satoshi Ichikawa1, Noriko Fukuhara1, Shunsuke Hatta1, Masahito Himuro1, Kentaro Nasu1, Koya Ono1, Yoko Okitsu1, Masahiro Kobayashi1, Yasushi Onishi1, Masaki Ri2, Ryo Ichinohasama3, Hideo Harigae1.   

Abstract

Entities:  

Keywords:  anaplastic multiple myeloma; autologous hematopoietic stem cell transplantation; high-dose chemotherapy

Mesh：

Substances：

Year:  2018        PMID： 29553093      PMCID： PMC6144193          DOI： 10.3960/jslrt.17035

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN： 1346-4280


× No keyword cloud information.
  6 in total

1.  Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.

Authors:  Wenjiao Tang; Yangfan Xu; Bing Xiang
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

2.  Anaplastic multiple myeloma with MYC rearrangement.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ko Hashimoto; Fumiyoshi Fujishima; Ryo Ichinohasama; Hideo Harigae
Journal:  Leuk Res Rep       Date:  2021-12-27

3.  CD38 - Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report.

Authors:  An Thi Vinh Do; Le Lan Anh
Journal:  Cureus       Date:  2022-01-03

4.  Anaplastic plasma cell myeloma - A morphological dilemma.

Authors:  Thulasi Raman Ramalingam; Lakshman Vaidhyanathan; Prabu Pandurangan
Journal:  Hematol Transfus Cell Ther       Date:  2020-08-05

5.  Anaplastic Multiple Myeloma: Case Series and Literature Review.

Authors:  Jian Wu; Emily Chu; Cristiana Costa Chase; Taewoong Choi; Cristina Gasparetto; Ken Young; Yubin Kang
Journal:  Asploro J Biomed Clin Case Rep       Date:  2022-01-15

6.  Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.

Authors:  Masuho Saburi; Masao Ogata; Yasuhiro Soga; Yoshiyuki Kondo; Ryo Kurimoto; Kazuhito Itani; Kazuhiro Kohno; Hiroki Uchida; Toshiyuki Nakayama
Journal:  J Clin Exp Hematop       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.